ArticleActive
Billing and Coding: MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) Testing
A55235
Wisconsin Physicians Service Insurance Corporation (J05)
Effective: July 27, 2023
Updated: December 31, 2025
Policy Summary
MolDX considers genetic testing for Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C)—including multi-gene panels (e.g., RYR2, TMEM43, DSP, PKP2, DSG2, DSC2, JUP) billed with CPT 81439—to be a statutorily excluded service and not covered. Claims should include the appropriate diagnosis and DEX Z-Code in the specified claim fields; ABNs are not required for excluded services (use GX for voluntary ABN and GY to indicate statutory exclusion).
Coverage Criteria Preview
Key requirements from the full policy
"Genetic testing for Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C), including multi-gene panels (e."
Sign up to see full coverage criteria, indications, and limitations.